| The Nonparametric Behrens-Fisher Problem with Dependent Replicates A Roy The University of Texas at Dallas, 2020 | 12 | 2020 |
| PSMA-positive circulating tumor cell detection and outcomes with abiraterone or enzalutamide treatment in men with metastatic castrate-resistant prostate cancer S Gupta, S Halabi, Q Yang, A Roy, A Tubbs, Y Gore, DJ George, ... Clinical Cancer Research 29 (10), 1929-1937, 2023 | 8 | 2023 |
| Inter-reader variability using PI-RADS v2 versus PI-RADS v2. 1: most new disagreement stems from scores 1 and 2 NL Beetz, M Haas, A Baur, F Konietschke, A Roy, CA Hamm, ... RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden …, 2022 | 7 | 2022 |
| Radiographic progression-free survival as a surrogate endpoint of overall survival in men with metastatic castrate-resistant prostate cancer. S Halabi, A Roy, Q Yang, W Xie, WK Kelly, C Sweeney Journal of Clinical Oncology 39 (15_suppl), 5057-5057, 2021 | 7 | 2021 |
| Time series methodology in storj token prediction D Chakraborty, A Roy 2019 International Conference on Data Mining Workshops (ICDMW), 224-231, 2019 | 4 | 2019 |
| External validation of a prognostic model of overall survival in men with chemotherapy-naïve metastatic castration-resistant prostate cancer S Halabi, Q Yang, A Roy, B Luo, JC Araujo, C Logothetis, CN Sternberg, ... Journal of Clinical Oncology 41 (15), 2736-2746, 2023 | 3 | 2023 |
| Assessing intermediate clinical endpoints (ICE) as potential surrogates for overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC). S Halabi, A Roy, L Rydzewska, P Godolphin, MKB Parmar, MHA Hussain, ... Journal of Clinical Oncology 40 (16_suppl), 5006-5006, 2022 | 3 | 2022 |
| Radiographic progression-free survival and clinical progression-free survival as potential surrogates for overall survival in men with metastatic hormone-sensitive prostate cancer S Halabi, A Roy, L Rydzewska, S Guo, P Godolphin, M Hussain, ... Journal of Clinical Oncology 42 (9), 1044-1054, 2024 | 1 | 2024 |
| Clinical Rounds in Hepatology V Singh, A Roy Springer, 2022 | 1 | 2022 |
| 1837P Assessing PSA S Halabi, A Roy, S Guo, L Rydzewska, PJ Godolphin, MK Parmar, ... Annals of Oncology 34, S994-S995, 2023 | | 2023 |
| PARAMETRIZATION OF WEATHER RESEARCH FORECAST MODEL OVER WESTERN HIMALAYAN REGION–INDIA S Kumari, A Roy The International Archives of the Photogrammetry, Remote Sensing and Spatial …, 2023 | | 2023 |
| The relationship between a priori defined prognostic risk groups and and overall survival (OS) in men with metastatic hormone sensitive prostate cancer (mHSPC). S Halabi, SS Guo, A Roy, L Rydzewska, P Godolphin, MHA Hussain, ... Journal of Clinical Oncology 41 (16_suppl), 5073-5073, 2023 | | 2023 |
| 1375P Intermediate clinical endpoints (ICE) as potential surrogates for overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC) S Halabi, A Roy, L Rydzewska, P Godolphin, MK Parmar, M Hussain, ... Annals of Oncology 33, S1171, 2022 | | 2022 |
| Primary Biliary Cholangitis S Mishra, A Roy, V Singh Clinical Rounds in Hepatology, 101-109, 2022 | | 2022 |
| Acute Liver Failure A Singh, A Roy, V Singh Clinical Rounds in Hepatology, 9-14, 2022 | | 2022 |
| Approach to Biliary Obstruction and Evaluation of Biliary Stricture P Debnath, A Roy, V Singh Clinical Rounds in Hepatology, 169-176, 2022 | | 2022 |
| Selected Topics in Transplant Hepatology K Amarjit, A Roy, V Singh Clinical Rounds in Hepatology, 153-159, 2022 | | 2022 |
| Practical Management of Chronic Hepatitis C A Roy, V Singh Clinical Rounds in Hepatology, 23-33, 2022 | | 2022 |
| WITHDRAWN: Progress in Hepatology: Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study A Roy, N Verma Journal of Clinical and Experimental Hepatology, 2022 | | 2022 |
| Inter-Reader Variability Using PI-RADS v2 Versus PI-RADS v2. 1: Most New Disagreement Stems from Scores 1 and 2 Vergleich der Interrater-Reliabilität von PI-RADS v2 und PI-RADS … NL Beetz, M Haas, A Baur, F Konietschke, A Roy, CA Hamm, ... | | 2022 |
Susan Halabi, PhD, FSCT, FASA, FAS...Duke UniversityVerified email at duke.edu
